MNMD Mind Medicine (MindMed) Inc.

Nasdaq mindmed.co


$ 13.90 $ 1.74 (14.61 %)    

Friday, 17-Oct-2025 19:43:00 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 13.65
$ 11.67
$ 13.50 x 100
$ 13.95 x 11
$ 11.56 - $ 13.86
$ 4.70 - $ 13.86
3,794,951
na
1.04B
$ 1.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-06-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-28-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mind-medicine-analyst-cites-strong-phase-3-pipeline-for-anxiety-depression

Needham starts MindMed at Buy with a $28 target, citing strong Phase 3 prospects for MM120 in anxiety and depression and solid ...

Core News & Articles

https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-sugge...

 needham-initiates-coverage-on-mind-medicine-with-buy-rating-announces-price-target-of-28

Needham analyst Ami Fadia initiates coverage on Mind Medicine (NASDAQ:MNMD) with a Buy rating and announces Price Target of ...

Core News & Articles

https://www.marijuanamoment.net/new-york-lawmakers-hold-hearing-psilocybins-medical-benefits-amid-broader-debate-over-psychedel...

 mindmed-study-finds-nearly-half-of-adults-with-severe-anxiety-report-suicidal-thoughts-almost-every-day

Researchers from Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (the "Company" or "MindMed"), a late-stage clinica...

Core News & Articles

https://www.marijuanamoment.net/massachusetts-lawmakers-approve-bill-to-create-psychedelic-therapy-pilot-program/

 mindmed-publishes-phase-2b-mm120-lsd-results-in-jama-demonstrating-statistically-significant-and-sustained-anxiety-reduction-in-gad-patients-100-g-dose-achieved-65-response-48-remission-at-week-12-supporting-ongoing-phase-3-trials-and-fda-breakthrough-therapy-designation

The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a sing...

Core News & Articles

https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/

Core News & Articles

https://www.marijuanamoment.net/gop-senator-is-confident-psychedelics-access-will-expand-under-trump-saying-many-veterans-speak...

Core News & Articles

https://www.marijuanamoment.net/u-s-senate-committee-to-hold-hearing-on-benefits-of-psychedelics-for-military-veterans/

 oppenheimer-reinstates-outperform-on-mind-medicine-announces-25-price-target

Oppenheimer analyst Jay Olson reinstates Mind Medicine (NASDAQ:MNMD) with a Outperform and announces $25 price target.

 chardan-capital-maintains-buy-on-mind-medicine-maintains-20-price-target

Chardan Capital analyst Rudy Li maintains Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $20 price target.

 mind-medicine-q2-eps-050-misses-037-estimate

Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.3...

Core News & Articles

https://www.marijuanamoment.net/massachusetts-psychiatric-society-endorses-bill-to-decriminalize-psilocybin-possession/

Core News & Articles

https://www.marijuanamoment.net/california-governor-hes-all-in-on-psychedelic-therapy-access-but-worries-about-capitalists-comm...

Core News & Articles

https://www.washingtonpost.com/health/2025/07/16/psychedelics-rfk-jr-kennedy-ibogaine-mdma/41658b06-6246-11f0-bf70-56d8888ebb94...

Core News & Articles

https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests

Core News & Articles

https://www.bloomberg.com/news/articles/2025-06-30/colorado-moves-to-allow-hallucinogen-ibogaine-for-medical-use?embedded-check...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION